In order to confirm the phenotype of the immune-selected hDPSCs the expression of the stemness markers STRO-1 and c-Kit, the neural crest-related antigens nestin and SOX10, and the immunomodulatory molecule FasL was investigated. Subsequently, the multipotency of the STRO-1+/c-Kit+ hDPSCs population was demonstrated by culturing cells in appropriate differentiation media to reach osteogenic, myogenic and glial differentiation, respectively, as formerly described (Di Tinco et al., 2021a; Zordani et al., 2019 (link); Carnevale et al., 2018 (link)). At the end of each differentiation experiment, the commitment was evaluated by assessing the expression of lineage related markers with the use of the following primary antibodies: mouse anti-osteocalcin (OCN), rabbit anti-RUNX2 (Abcam), mouse anti-myogenin, rabbit anti-desmin and rabbit anti-S100b (all from Sigma Aldrich). Confocal immunofluorescence analyses were performed as detailed below.
Free full text: Click here